Finch Therapeutics Group Revenue

In the year 2023, Finch Therapeutics Group had annual revenue of $107.00K, down -87.57%.

Revenue

107.00K

Revenue Growth

-87.57%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

21.28M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	107.00K	-754.00K	-87.57%
Dec 31, 2022	861.00K	-17.67M	-95.35%
Dec 31, 2021	18.53M	10.81M	140.08%
Dec 31, 2020	7.72M	-2.44M	-23.98%
Dec 31, 2019	10.15M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
HOOKIPA Pharma	9.35M
Zeo ScientifiX	5.20M
Harvard Apparatus Regenerative Technology	743.00K
Zenith Capital	500.00K
Provectus Biopharmaceuticals	350.44K
ZIVO Bioscience	209.03K

Revenue Rankings

Finch Therapeutics Group News

10 months ago - Arquitos Capital's Largest Holdings For Q1 2025 - Seeking Alpha
1 year ago - Finch Announces Delisting from Nasdaq and SEC Deregistration - GlobeNewsWire
2 years ago - Finch Announces Reverse Stock Split of Common Stock - GlobeNewsWire
3 years ago - Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates - GlobeNewsWire
3 years ago - Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women's Hospital and Updates to University of Minnesota License Agreement - GlobeNewsWire
3 years ago - Finch Therapeutics: Why This Finch Could Fly - An Asymmetric Risk/Reward Opportunity - Seeking Alpha
3 years ago - Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates - GlobeNewsWire
3 years ago - Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other Assets - GlobeNewsWire

More News